Joinn Laboratories(China)Co.,Ltd.
603127
Ранг среди акций
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Цена акции
$6.82
Рыночная капитализация
$4.30B
Изменение (1 день)
-6.30%
Изменение (1 год)
48.79%
Страна
CN
Торговля Joinn Laboratories(China)Co.,Ltd. (603127)
Категория
Healthcare
Прибыль Joinn Laboratories(China)Co.,Ltd. (603127)
Прибыль на 2026 TTM: 0
Согласно последним финансовым отчетам Joinn Laboratories(China)Co.,Ltd., текущая прибыль компании составляет 0. В 2026 году компания получила прибыль 0, равна прибыли за 2026, которая составила 0. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Joinn Laboratories(China)Co.,Ltd. с 2012 по 2026
Прибыль в конце каждого года
| Год | Прибыль | Изменить |
|---|---|---|
| 2025 | $48.24M | 238.43% |
| 2024 | $14.25M | -80.10% |
| 2023 | $71.62M | -60.16% |
| 2022 | $179.77M | 77.97% |
| 2021 | $101.01M | 83.00% |
| 2020 | $55.19M | 78.38% |
| 2019 | $30.94M | 66.47% |
| 2018 | $18.59M | 29.46% |
| 2017 | $14.36M | 63.39% |
| 2016 | $8.79M | -1.08% |
| 2015 | $8.88M | -12.00% |
| 2014 | $10.09M | 132.26% |
| 2013 | $4.35M | 289.26% |
| 2012 | $1.12M | 0.00% |
Прибыль схожих компаний или конкурентов
| Компания | Прибыль | Разница в прибыли | Страна |
|---|---|---|---|
| $7.87B | - |
US
|
|
| $4.82B | - |
US
|
|
| $-252.70M | - |
US
|
|
| - | - |
CN
|
|
| $1.66B | - |
US
|
